Marialaura Marchetti was born in 1987 in Reggio Emilia, Italy. In 2011 she obtained the MSc with honors in Molecular Biology at the Department of Biochemistry and Molecular Biology of the University of Parma (Parma, Italy). In 2015 she obtained the Doctorate in Biochemistry and Molecular Biology at the University of Parma with a dissertation entitled "Biochemical characterization of human serine racemase: substrates, inhibitors and allosteric effectors". From 2015 to 2017, she actively took part as a Post-Doc (University of Parma) in a Telethon-granted project aimed at the development of an enzymatic uricolytic therapy for the treatment of hypoxanthine-guanine phosphoribosyltransferase deficiency; she contributed to the kinetic characterization of the candidate enzymes and their modification by PEGylation for stability improvement, and to the set-up of an enzymatic biosensor for the evaluation of S-allantoin levels in biological samples. From 2017, as a Post-Doc at the Universities of Parma and Torino (Torino, Italy), she has been involved in the study of bacterial proteins as putative targets for the development of new antimicrobials, with a particular focus on cysteine biosynthetic enzymes and iron-acquisition machineries. From 2021, she is Assistant Professor in Applied Physics at the Department of Medicine and Surgery of the University of Parma.
